Home / Journals / CJU / Vol.13, No.6, 2006
Special Issues
Table of Content
  • Open AccessOpen Access

    EDITORIAL

    The Canadian Journal of Urology expands its horizon

    Gabriel P. Haas
    Canadian Journal of Urology, Vol.13, No.6, pp. 3307-3307, 2006
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    ARTICLE

    Screening asymptomatic siblings for vesicoureteral reflux: sound science or religious rhetoric?

    A. E. MacNeily, K. Afshar
    Canadian Journal of Urology, Vol.13, No.6, pp. 3309-3316, 2006
    Abstract Introduction: Many urologists endorse the concept of screening asymptomatic siblings of children known to have vesicoureteral reflux. Others oppose screening until there is better evidence to justify the cost and potential morbidity of adopting a widespread screening program.
    Methods: A literature review of the following topics was carried out: 1) screening programs in general; 2) reflux in general; 3) familial reflux; and 4) screening for familial reflux.
    Results: The evidence supporting our traditional surgical and medical management strategies for reflux is weak. The evidence supporting screening is lacking. Public Health organizations do not address the issue of screening… More >

  • Open AccessOpen Access

    ARTICLE

    Risk of post-operative intravesical mitomycin C instillation following transurethral bladder tumor resection

    Oleg Shapiro1, Karen Jones2, Ching Wang1, Steve Landas2, Gabriel P. Haas1
    Canadian Journal of Urology, Vol.13, No.6, pp. 3317-3320, 2006
    Abstract Bladder cancer is the fifth most common cancer in the Western world and is on the rise. Most patients present with superficial disease and are treated by transurethral resection of bladder tumor. More than half of these patients experience recurrence with about 20% progressing to muscle invasive disease. Intravesical chemotherapy has been shown to decrease the risk of recurrence of bladder cancer. Mitomycin C has emerged as a major agent for an immediate post-resection intravesical instillation. This article reviews the literature on the mode of action, rationale for immediate adjuvant treatment with mitomycin C and More >

  • Open AccessOpen Access

    ARTICLE

    A randomized controlled trial comparing two educational booklets on prostate cancer

    Deb Feldman-Stewart1,2, Michael D. Brundage1,2,3, Rob Siemens4, David Skarsgard5
    Canadian Journal of Urology, Vol.13, No.6, pp. 3321-3326, 2006
    Abstract Purpose: To compare the helpfulness of two educational aids or booklets on early-stage prostate cancer.
    Method: Participating consecutive patients and a family member, in three centres, received one of two booklets, one produced by AstraZeneca (AZ), the other produced by us (CCE); the patient and family shared a booklet but were separate study participants. The primary outcome was the Purpose-based Information Assessment completed after participants read their booklet; they rated the importance (4-point Likert scale) of six potential purposes for the information: to help organize their thoughts, understand their situations, decide on treatment, plan, provide emotional support… More >

  • Open AccessOpen Access

    ARTICLE

    Controversies in prostate cancer staging implementation at a tertiary cancer center

    Tracy Sexton1,2, George Rodrigues1,2,3, Ed Brecevic1,2, Laura Boyce1, Denise Parrack1, Michael Lock1,2, David D’Souza1,2
    Canadian Journal of Urology, Vol.13, No.6, pp. 3327-3334, 2006
    Abstract Objective:To assess accuracy of recorded prostate cancer stage after implementation of a quality assurance staging improvement plan.
    Methods and materials:Genitourinary multidisciplinary TNM staging guidelines were prospectively implemented. Educational programs for health records technicians (HRT) and clinicians preceded implementation of the new guidelines. Patient stage information was entered into the Oncology Patient Information System (OPIS) as part of the usual operations of the cancer center by an HRT. Physician and HRT auditors performed a subsequent quality assurance audit on 97 prostate cancer patients seen over a 2-month period. Assessment of staging accuracy and reasons for discrepancies between the… More >

  • Open AccessOpen Access

    ARTICLE

    Prednisone monotherapy in asymptomatic hormone refractory prostate cancer

    Daniel Y. C. Heng, Kim N. Chi
    Canadian Journal of Urology, Vol.13, No.6, pp. 3335-3339, 2006
    Abstract Background: Patients with advanced prostate cancer eventually cease to respond to hormonal therapy and thus progress to hormone refractory prostate cancer (HRPC). Prednisone has been used in this setting; however, limited data is available for this monotherapy in the asymptomatic HRPC population.
    Objective: To evaluate the PSA response rate to prednisone in asymptomatic patients with hormone refractory prostate cancer (HRPC). Secondary objectives were to determine toxicity, predictors of response, and to determine overall survival of this population.
    Methods: Patients with asymptomatic HRPC that were treated with low dose prednisone from April 1998 to 2003 were identified from the… More >

  • Open AccessOpen Access

    HOW I DO IT

    Comparison of laparoscopic and open nephrectomy for adult polycystic kidney disease: operative challenges and technique

    Saleh Binsaleh1, Patrick P. Luke2, Christopher Nguan2, Anil Kapoor1
    Canadian Journal of Urology, Vol.13, No.6, pp. 3340-3345, 2006
    Abstract Objectives: Autosomal dominant polycystic kidney disease an inherited systemic disorder is characterized by the development of multiple cysts in the kidneys and other organs. When nephrectomy is indicated, the laparoscopic approach is challenging due to the massive size of these kidneys. We present our technique and evaluate the surgical outcomes of laparoscopic versus open nephrectomy for patients with such condition.
    Materials and methods: A retrospective review was done for six laparoscopic and six open nephrectomies performed by two laparoscopic surgeons in two university hospitals between January 2004 and December 2004. Preoperative, intraoperative, and postoperative data are presented.… More >

  • Open AccessOpen Access

    CASE REPORT

    Presentation of a functional pituitary adenoma as a significant decrease in prostate-specific antigen level in a patient followed for prostate cancer

    Aaron B. Grotas, Harris M. Nagler
    Canadian Journal of Urology, Vol.13, No.6, pp. 3346-3347, 2006
    Abstract The stimulatory role of testosterone in the production and release of prostate-specific antigen (PSA) has been well characterized. Testosterone production by the testes is dependent on a functional hypothalamic-pituitary-gonadal axis. High prolactin levels have been shown to disrupt this axis, resulting in decreases in gonadotropins and testosterone levels. We report a patient with prostate cancer and elevated PSA levels followed with “watchful waiting” for several years who experienced a precipitous decrease in PSA level over a 3 month period. The patient was found to have an asymptomatic prolactin-secreting pituitary macroadenoma. More >

  • Open AccessOpen Access

    CASE REPORT

    Malignant cystic nephroma


    Canadian Journal of Urology, Vol.13, No.6, pp. 3348-3350, 2006
    Abstract Aim: To describe a malignant cystic nephroma in an asymptomatic man.
    Methods: Case report and review of the literature.
    Results: A 60-year-old white male presented with an incidentally discovered right perirenal mass. An MRI demonstrated a large perinephric encapsulated mass with diffuse heterogeneity. Patient underwent a radical nephrectomy and retroperitoneal node dissection. Histopathological analyses of the resected specimen revealed malignant cystic nephroma.
    Conclusion: This represents the first published report of this rare tumor in an adult patient. More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Subcutaneous reservoir placement during penile prosthesis implantation

    M. C. Smaldone, G. M. Cannon Jr, R. M. Benoit
    Canadian Journal of Urology, Vol.13, No.6, pp. 3351-3352, 2006
    Abstract Currently, the prosthesis of choice for patients undergoing penile prosthesis surgery is a three piece inflatable device, as this provides optimal inflation and deflation when compared to a one or two piece prosthesis. However, prior pelvic surgery or radiation therapy can obliterate the retropubic space and make placement of the reservoir required for a three piece prosthesis difficult. We report a novel location for reservoir placement in a man who had undergone multiple pelvic surgeries after suffering a severe pelvic crush injury. More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Surgical modifications in bladder neck reconstruction and vesicourethral anastomosis during radical retropubic prostatectomy to reduce bladder neck contractures

    Marcelo A. Orvieto, Kevin C. Zorn, Ofer N. Gofrit, James Anderson, Gregory P. Zagaja, Charles B. Brendler
    Canadian Journal of Urology, Vol.13, No.6, pp. 3353-3357, 2006
    Abstract Purpose: We describe surgical modifications in radical retropubic prostatectomy (RRP) which have significantly reduced the incidence of bladder neck contractures (BNC).
    Materials and methods: Between March 1994-July 2005, 977 men underwent a RRP by a single surgeon. Group I comprised 548 patients operated upon July 1994-December 1999, without the modifications described below. Group II comprised 429 men operated upon January 2000-December 2004, with the following surgical modifications: 1) reconstruction of the bladder neck (BN) to a diameter of 28 French; 2) placement of the posterior (6 o'clock) vesicourethral suture on mild traction before placing this suture into… More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    The efficacy of the Dornier Doli S lithotripter for renal stones

    Christopher C. Hoag, William N. Taylor, Victor A. Rowley
    Canadian Journal of Urology, Vol.13, No.6, pp. 3358-3363, 2006
    Abstract Introduction: There is little documentation of the efficacy of the Doli-S lithotripter. This study investigated the outcome of ESWL with the Doli-S lithotripter on previously untreated renal calculi.
    Methods: Over a 12-month period, 105 consecutive patients with renal stones, treated by a single urologist were enrolled in the study. None of the stones were previously treated. Data gathered included stone characteristics and treatment characteristics. Treatment was to an endpoint of either fluoroscopically successful fragmentation or to 2500 shockwaves. Patients were followed with KUBs, ultrasounds, or CT-KUBs to assess residual stone burden. Treatment success was defined as… More >

Per Page:

Share Link